Trial intelligence / Profile preview

Dexmedetomidine for NIV after chest trauma

NCT02537366Phase 4Completed

Sponsor
CHU Grenoble Alpes
Start
Sep 2015
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in thoracic injury, sponsored by CHU Grenoble Alpes. Started Sep 2015; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

thoracic injury

Beyond the preview

Go deeper on NCT02537366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02537366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call